Replies to post #448979 on Anavex Life Sciences Corp (AVXL)

[georgejjl]

The pediatric Rett syndrome EXCELLENCE trial did NOT fail and yes, Anavex can get the voucher if the FDA approves blarcamesine for the treatment of Rett syndrome before blarcamesine is approved for the treatment of Alzheimer's disease.

GOD bless,

[Rubyred77]

Where did it say primary and secondary endpoints failed?

[bas2020]

The Rett data in total, along with QoL improvements in the lives of the patients will be what moves blarcamesine to approval... yes.